Take part in a pharmaceutical market research study on the myelofibrosis patient
journey
About this study
The study is sponsored and funded by a pharmaceutical company. MPN Voice have been
paid for their consultancy work to contribute to the design of the market research and help
with recruiting eligible participants.
The study, conducted by Ipsos, an independent market research company, on behalf of the
pharmaceutical company, will survey people in the UK who have been diagnosed with
myelofibrosis (MF), and carers of those diagnosed with myelofibrosis (MF). It aims to improve
understanding of people’s experience of being diagnosed and treated for myelofibrosis.
Why take part?
Your voice matters and by sharing your experiences, you can:
• Help doctors, nurses and other healthcare professionals understand your perspective
• Raise awareness of the impact myelofibrosis has on the people it affects
• Help identify areas for improvement to ensure patients with myelofibrosis receive the
…best care
Who can take part?
You might be eligible if you:
• Are over 18 years old
• Have been diagnosed with myelofibrosis or are a (non-professional) carer for a family
…member, neighbour, or friend who has been diagnosed with myelofibrosis
• Have seen a healthcare professional in the last 12 months for the management of your
…myelofibrosis/ the myelofibrosis of the person you care for
How to take part?
If you would like to know more about the research, please contact
apply@liberatingresearch.com
• When registering your interest, please include the following code in the email subject
…description : LRQ3733
Participants will be asked to complete an online survey which will take approximately 20
minutes.
Participants will be paid for contributing their valuable time at a fair market value amount of £20
each, with 10% of this payment being contributed to a chosen charity.
Your personal information and responses will remain confidential.
Thank you very much for your time.
MPN Voice
NX-GB-MML-WCNT-250001 September 2025
